Status: current, Primitive. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4558321000168117 | crizanlizumab (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4558331000168119 | crizanlizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| crizanlizumab | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| crizanlizumab 100 mg/10 mL injection, vial | has Australian BoSS | True | crizanlizumab | Inferred relationship | Some | 1579693436 |
| crizanlizumab 100 mg/10 mL injection, vial | has intended active ingredient | True | crizanlizumab | Inferred relationship | Some | 1579693436 |
| crizanlizumab | has intended active ingredient | True | crizanlizumab | Inferred relationship | Some | 21563183 |
| Adakveo 100 mg/10 mL injection, 10 mL vial | has intended active ingredient | True | crizanlizumab | Inferred relationship | Some | 1227996182 |
| Adakveo 100 mg/10 mL injection, 10 mL vial | has Australian BoSS | True | crizanlizumab | Inferred relationship | Some | 1227996182 |
This concept is not in any reference sets
FHIR